Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Effect of Iron/Zinc-Biofortified Pearl Millet on Growth and Immunity in Children Aged 12-18 Months in India [NA]

View source ↗

Summary

A completed trial in India evaluated whether iron- and zinc-biofortified pearl millet improves growth and immune function in children aged 12-18 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cornell University | Conditions: Iron Deficiency, Zinc Deficiency | NA | Status: COMPLETED | Results posted: 2026-03-09